Trials / Completed
CompletedNCT04013477
Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults
A Single-blinded, Placebo- and Active-controlled, Parallel, Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DA-5207 Transdermal Delivery System in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A single-blinded, placebo- and active-controlled, parallel, single-ascending dose phase 1 clinical trial to evaluate the safety and pharmacokinetics of DA-5207 transdermal delivery system in healthy adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-5207 | DA-5207 Transdermal Delivery System |
| DRUG | Donepezil Hydrochloride | donepezil HCl 10mg QD |
Timeline
- Start date
- 2019-06-18
- Primary completion
- 2019-12-05
- Completion
- 2020-04-06
- First posted
- 2019-07-09
- Last updated
- 2021-04-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04013477. Inclusion in this directory is not an endorsement.